# FST-201 In The Treatment of Acute Otitis Externa

> **NCT00945802** · PHASE3 · TERMINATED · sponsor: **Shire** · enrollment: 5 (actual)

## Conditions studied

- Acute Otitis Externa

## Interventions

- **DRUG:** FST-201 (dexamethasone 0.1%) Otic Suspension
- **DRUG:** ciprofloxacin 0.3%, dexamethasone 0.1%

## Key facts

- **NCT ID:** NCT00945802
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-07-31
- **Primary completion:** 2010-07-31
- **Final completion:** 2010-07-31
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2021-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00945802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00945802, "FST-201 In The Treatment of Acute Otitis Externa". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00945802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*